Oxford Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-13,009
| Closed | -$309K | – | 1177 |
|
|
2019
Q4 | $309K | Buy |
+13,009
| New | +$309K | 0.01% | 1426 |
|
|
2019
Q2 | – | Sell |
-97,242
| Closed | -$3.41M | – | 1950 |
|
|
2019
Q1 | $3.41M | Buy |
97,242
+50,866
| +110% | +$1.78M | 0.07% | 327 |
|
|
2018
Q4 | $1.54M | Buy |
+46,376
| New | +$1.54M | 0.04% | 621 |
|
|
2018
Q2 | – | Sell |
-28,015
| Closed | -$1.28M | – | 1913 |
|
|
2018
Q1 | $1.28M | Sell |
28,015
-24,446
| -47% | -$1.12M | 0.03% | 810 |
|
|
2017
Q4 | $2.12M | Buy |
52,461
+28,703
| +121% | +$1.16M | 0.05% | 541 |
|
|
2017
Q3 | $947K | Buy |
+23,758
| New | +$947K | 0.02% | 958 |
|
|
2017
Q2 | – | Sell |
-68,285
| Closed | -$2.14M | – | 1696 |
|
|
2017
Q1 | $2.14M | Buy |
68,285
+37,041
| +119% | +$1.16M | 0.05% | 442 |
|
|
2016
Q4 | $789K | Sell |
31,244
-98,581
| -76% | -$2.49M | 0.03% | 514 |
|
|
2016
Q3 | $3.21M | Sell |
129,825
-148,843
| -53% | -$3.68M | 0.1% | 276 |
|
|
2016
Q2 | $5.68M | Sell |
278,668
-62,958
| -18% | -$1.28M | 0.19% | 121 |
|
|
2016
Q1 | $5.21M | Sell |
341,626
-49,368
| -13% | -$753K | 0.15% | 152 |
|
|
2015
Q4 | $5.35M | Buy |
390,994
+110,028
| +39% | +$1.51M | 0.13% | 170 |
|
|
2015
Q3 | $3.94M | Sell |
280,966
-430,163
| -60% | -$6.04M | 0.12% | 172 |
|
|
2015
Q2 | $12.1M | Buy |
711,129
+638,190
| +875% | +$10.8M | 0.33% | 53 |
|
|
2015
Q1 | $882K | Buy |
+72,939
| New | +$882K | 0.02% | 479 |
|